794
Views
4
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR

An analysis of planned versus delivered airway doses during stereotactic lung radiotherapy for central tumors

, , , &
Pages 934-937 | Received 25 Oct 2015, Accepted 23 Dec 2015, Published online: 15 Feb 2016

References

  • Vansteenkiste J, Crinò L, Dooms C, Douillard JY, Faivre-Finn C, Lim E. Panel Members, et al. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014;25:1462–74.
  • Timmerman RD, Herman J, Cho LC. Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol 2014;32:2847–54.
  • Roach MC, Videtic GM Bradley JD, Iaslc Advanced Radiation Technology Committee. Treatment of Peripheral Non-Small Cell Lung Carcinoma with Stereotactic Body Radiation Therapy. J Thorac Oncol 2015;10:1261–7.
  • Chang JY, Bezjak A Mornex F, Iaslc Advanced Radiation Technology Committee. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. J Thorac Oncol 2015;10:577–85.
  • Senthi S, Haasbeek CJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. Radiother Oncol 2013;106:276–82. Erratum in: Radiother Oncol 2013; 109:183.
  • Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833–9.
  • Dahele M, Tekatli H, Senan S. Stereotactic body radiotherapy for central lung tumours. Br J Radiol 2015;88:20150410.
  • Nishimura S, Takeda A, Sanuki N, Ishikura S, Oku Y, Aoki Y, et al. Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors. J Thorac Oncol 2014;9:1370–6.
  • Haseltine JM, Rimner A, Gelblum DY, Modh A, Rosenzweig KE, Jackson A, et al. Fatal complications after SBRT for central lung tumors abutting the proximal bronchial tree. Pract Radiat Oncol doi: 10.1016/j.prro.2015.09.012.
  • Tekatli H, Senan S, Dahele M, Slotman BJ, Verbakel WF. Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes. Radiother Oncol 2015;117:64–70.
  • Dahele M, Verbakel W, Cuijpers J, Slotman B, Senan S. An analysis of patient positioning during stereotactic lung radiotherapy performed without rigid external immobilization. Radiother Oncol 2012;104:28–32.
  • Peguret N, Dahele M, Cuijpers JP, Slotman BJ, Verbakel WF. Frameless high dose rate stereotactic lung radiotherapy: intrafraction tumor position and delivery time. Radiother Oncol 2013;107:419–22.
  • Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, et al. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer 2015;89:50–6.
  • Chang JY, Li QQ, Xu QY, Allen PK, Rebueno N, Gomez DR, et al. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a “no fly zone”. Int J Radiat Oncol Biol Phys 2014;88: 1120–8.
  • van Sörnsen de Koste JR, Dahele M, Mostafavi H, Sloutsky A, Senan S, Slotman BJ, et al. Markerless tracking of small lung tumors for stereotactic radiotherapy. Med Phys 2015;42:1640–52.
  • Mutic S, Dempsey JF. The ViewRay system: magnetic resonance-guided and controlled radiotherapy. Semin Radiat Oncol 2014; 24:196–9.
  • Lagendijk JJ, Raaymakers BW, van Vulpen M. The magnetic resonance imaging-linac system. Semin Radiat Oncol 2014;24:207–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.